Second Circuit Upholds Dismissal of The Gap Securities Fraud Claim
The Second Circuit affirmed dismissal of a securities fraud complaint against The Gap, Inc.
Why it matters: This ruling clarifies legal standards for securities fraud claims involving risk disclosures, impacting investors, companies, and legal strategies in securities litigation.
- The Second Circuit ruled on May 28, 2026, upholding dismissal in Smith v. The Gap, Inc.
- The case involved risk disclosures about overestimated demand for The Gap's BODEQUALITY plus-size line.
- Generic risk disclosures addressing common industry risks were deemed not misleading.
- Optimistic statements about demand were ruled unactionable puffery under securities law.
- The court rejected a duty to disclose all factors affecting sales and inventory under Section 10(b) and Rule 10b-5.
On May 28, 2026, the United States Court of Appeals for the Second Circuit affirmed the dismissal of a securities fraud complaint against The Gap, Inc. in Smith v. The Gap, Inc..
The lawsuit arose after The Gap disclosed it had overestimated demand for its BODEQUALITY plus-size clothing line, resulting in surplus inventory sold at heavy discounts. Plaintiffs alleged securities fraud based on the company’s risk disclosures and statements about demand.
The court clarified that generic risk disclosures highlighting potential inventory misjudgments were not misleading, as they referenced common risks and acknowledged that such issues had occurred in the past. Specifically, the court rejected the plaintiffs’ claim that a risk disclosure is actionable merely because a risk later materialized, stating, "We reject Plaintiffs' proposed rule that a risk disclosure is actionable whenever a company fails to disclose that the risk already materialized in some way."
Additionally, the court deemed statements referring to demand as "strong" to be unactionable puffery — optimistic but not legally misleading. The decision also addressed the scope of disclosure obligations, emphasizing, "A company's decision to speak about one aspect of sales does not necessarily require it to address other issues." The court thus found no requirement under Section 10(b) of the Securities Exchange Act or SEC Rule 10b-5 to disclose every factor influencing sales or inventory.
This ruling distinguishes prior decisions where companies made assurances that known risks were unlikely to occur, affirming that generic risk warnings remain generally safe under securities laws even if the risk becomes real.
By the numbers:
- May 28, 2026 — Second Circuit decision date in Smith v. The Gap, Inc.
- BODEQUALITY — The Gap's plus-size clothing line at issue in the suit
- Section 10(b) and Rule 10b-5 — Key legal provisions analyzed